BCIQ Profiles

Company Profile Report
0212 HemoShear
BioCentury & Getty Images


$40M series A sets up HemoShear to complete evolution from service play to clinical-stage biotech 

Feb 13, 2021 | 3:06 AM GMT

After securing $40 million in its first institutional round this week, HemoShear will make the next step in its evolution from service play to drug developer with

Read the full 535 word article

How to gain access

Continue reading with a
two-week free trial.